Evidence map›Paper›PMID 42611929›Full record

ArticlePLoS pathogens2026

Loss of type I interferon signaling in Kupffer cells triggers viral spread and fatal liver damage in a mouse model of Crimean-Congo hemorrhagic fever.

Shintaro Yamada, Masayuki Shimojima, Takeshi Saito, Junki Maruyama, Hiroki Kato

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shintaro YamadaInstitute of Cardiovascular Immunology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Masayuki ShimojimaDepartment of Virology I, National Institute of Infectious Diseases, Japan Institute for Health Security, Musashimurayama, Tokyo, Japan.
Takeshi SaitoDepartment of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Junki MaruyamaDepartment of Pathology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.
Hiroki KatoInstitute of Cardiovascular Immunology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID 0000-0002-9571-4895

Funding

Viral factors responsible for Lassa virus pathogenicityR00AI156012 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MARUYAMA, JUNKI · 2023 to 2024
$498k
Viral factors responsible for Lassa virus pathogenicityK99AI156012 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MARUYAMA, JUNKI · 2021 to 2022
$177k
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)NIAID NIH HHS K99 AI156012NIAID NIH HHS R00 AI156012NIH HHS K99AI156012NIH HHS R00AI156012Overseas Research Fellowships from the Japanese Society for the Promotion of ScienceThe Microscopy Core Facility at University Hospital Bonn
6 · The paper itself

Abstract

Crimean-Congo hemorrhagic fever (CCHF), which is caused by infection with the CCHF virus (CCHFV), is the most widespread hemorrhagic infectious disease. In severe cases, liver damage is a salient manifestation. However, the detailed mechanism is not yet fully understood. To investigate the pathogenesis of CCHF-related liver damage, we infected type I interferon receptor 1 knockout (IFNAR1-/-) mice with Hazara virus (HAZV), which is a surrogate pathogen of CCHFV, as well as with the CCHFV itself. HAZV infection caused CCHF-like symptoms, including severe liver damage, alongside inflammatory responses. HAZV infection in IFNAR1-/- mice additionally lacking mitochondrial antiviral signaling protein (MAVS) induced minimal cytokine responses; however, these mice still exhibited weight loss and liver damage, albeit with a significantly delayed onset of lethal outcomes. We found that loss of liver-resident macrophage, Kupffer cells, occurred prior to viral spread in hepatocytes and liver damage in these mice. Notably, mice lacking IFNAR1 in Kupffer cells, but not mice lacking IFNAR1 in hepatocytes, also lost Kupffer cell population and exhibited lethal liver damage, following HAZV and CCHFV infection. Our findings indicate that IFNAR1 signaling in mononuclear phagocytes, especially Kupffer cells, is essential for preventing viral spread and fatal liver damage and raise the possibility that inflammatory cytokines- and viral replication-mediated Kupffer cell loss synergistically drives both processes.

Indexed as

Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoInterferon Type IKupffer CellsLiverReceptor, Interferon alpha-betaAnimalsDisease Models, AnimalMiceMice, Inbred C57BLMice, KnockoutSignal TransductionIfnar1 protein, mouseInterferon Type IReceptor, Interferon alpha-beta

Identifiers

PMID42611929
PMCPMC13577490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.